[The mechanism of arsenic trioxide-inducing apoptosis of K562 cells]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Oct;12(5):558-62.
[Article in Chinese]

Abstract

The aim was to investigate the mechanism of arsenic trioxide (ATO) inducing apoptosis of K562 cells that express P210Bcr-Abl. Apoptosis was analyzed by cell proliferation assay, morphological changes, DNA-PI staining and cell cycle analysis. ELISA kits were also used to analyze the concentration of cytosolic cytochrome C and activation of caspase-3. Transcriptional levels of Bcl-XL and Bcr-Abl were assayed by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). The results showed that K562 cells were induced to apoptosis after exposure to 2.5 micromol/L ATO for at least 48 hours, and the cell cycle of K562 cells was arrested at the G2/M phase. Caspase-3 was activated and there was a cytosolic accumulation of cytochrome C. ATO could only reduce the transcriptional level of Bcl-XL, but could not down-regulate the Bcr-Abl transcriptional level. In conclusion, ATO can induce K562 cells to apoptosis. The signal pathway mediated by the cytosolic translocation of mitochondria cytochrome C is one of the mechanisms for ATO inducing apoptosis. And the decrease of Bcl-XL may induce more apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Arsenic Trioxide
  • Arsenicals / pharmacology*
  • Caspase 3
  • Caspases / metabolism
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Cytochromes c / analysis
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • K562 Cells
  • Oxides / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • bcl-X Protein

Substances

  • Antineoplastic Agents
  • Arsenicals
  • BCL2L1 protein, human
  • Oxides
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • Cytochromes c
  • Fusion Proteins, bcr-abl
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Arsenic Trioxide